Bio Impact Capital LLC Werewolf Therapeutics, Inc. Call Options Transaction History
Bio Impact Capital LLC
- $623 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HOWL
# of Institutions
75Shares Held
32.1MCall Options Held
53.8KPut Options Held
1.3K-
Ra Capital Management, L.P. Boston, MA6.14MShares$16.7 Million0.23% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.28MShares$11.7 Million5.74% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.24MShares$8.82 Million0.41% of portfolio
-
Bank Of America Corp Charlotte, NC2.15MShares$5.84 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2MShares$5.44 Million0.01% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $80.3M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...